Biogen Netherlands B.V.
10 products tracked · names used in filings: Biogen Netherlands B.V.
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Zurzuvae zuranolone | Authorised | |
| 🇪🇺 | Aduhelm aducanumab | Application withdrawn | |
| 🇪🇺 | Qalsody tofersen | Authorised | 2024-05-29 |
| 🇪🇺 | Skyclarys omaveloxolone | Authorised | 2024-02-09 |
| 🇪🇺 | Vumerity diroximel fumarate | Authorised | 2021-11-15 |
| 🇪🇺 | Spinraza nusinersen | Authorised | 2017-05-30 |
| 🇪🇺 | Plegridy peginterferon beta-1a | Authorised | 2014-07-18 |
| 🇪🇺 | Tecfidera dimethyl fumarate | Authorised | 2014-01-30 |
| 🇪🇺 | Tysabri natalizumab | Authorised | 2006-06-27 |
| 🇪🇺 | Avonex interferon beta-1a | Authorised | 1997-03-13 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.